$XNCR
Xencor Inc

2019 Q2 Form 10-Q Financial Statement

#000155837019007346 Filed on August 07, 2019

View on sec.gov

Income Statement

Concept 2019 Q2 2018 Q2
Revenue $19.49M $0.00
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.800M $5.000M
YoY Change 16.0% 21.95%
% of Gross Profit
Research & Development $33.30M $23.33M
YoY Change 42.72% 38.06%
% of Gross Profit
Depreciation & Amortization $1.000M $900.0K
YoY Change 11.11% 80.0%
% of Gross Profit
Operating Expenses $39.06M $28.29M
YoY Change 38.06% 34.71%
Operating Profit -$19.57M -$28.29M
YoY Change -30.82%
Interest Expense $3.600M $2.500M
YoY Change 44.0% 150.0%
% of Operating Profit
Other Income/Expense, Net $3.588M $2.421M
YoY Change 48.2%
Pretax Income -$15.98M -$25.87M
YoY Change -38.21% 249.58%
Income Tax $50.00K $0.00
% Of Pretax Income
Net Earnings -$16.03M -$25.87M
YoY Change -38.02% 235.96%
Net Earnings / Revenue -82.29%
Basic Earnings Per Share -$0.28 -$0.46
Diluted Earnings Per Share -$0.28 -$0.46
COMMON SHARES
Basic Shares Outstanding 56.40M 55.68M
Diluted Shares Outstanding 56.40M 55.68M

Balance Sheet

Concept 2019 Q2 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $505.2M $255.4M
YoY Change 97.81% 35.49%
Cash & Equivalents $32.56M $35.29M
Short-Term Investments $472.6M $220.1M
Other Short-Term Assets $11.30M $12.10M
YoY Change -6.61% 59.21%
Inventory
Prepaid Expenses
Receivables $10.13M $1.300M
Other Receivables $400.0K $700.0K
Total Short-Term Assets $527.0M $269.5M
YoY Change 95.55% 27.73%
LONG-TERM ASSETS
Property, Plant & Equipment $12.13M $9.400M
YoY Change 29.02% 141.03%
Goodwill
YoY Change
Intangibles $13.52M
YoY Change
Long-Term Investments $121.0M $300.0M
YoY Change -59.67% 57.73%
Other Assets $10.73M $300.0K
YoY Change 3475.33% 50.0%
Total Long-Term Assets $157.7M $322.0M
YoY Change -51.01% 56.92%
TOTAL ASSETS
Total Short-Term Assets $527.0M $269.5M
Total Long-Term Assets $157.7M $322.0M
Total Assets $684.8M $591.5M
YoY Change 15.77% 42.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.994M $4.900M
YoY Change 83.55% -33.78%
Accrued Expenses $6.226M $5.900M
YoY Change 5.53% 47.5%
Deferred Revenue $45.50M
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $63.71M $71.20M
YoY Change -10.52% -33.71%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $13.00M $1.100M
YoY Change 1081.82% -85.14%
Total Long-Term Liabilities $13.00M $1.100M
YoY Change 1081.82% -85.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $63.71M $71.20M
Total Long-Term Liabilities $13.00M $1.100M
Total Liabilities $76.66M $72.30M
YoY Change 6.03% -37.02%
SHAREHOLDERS EQUITY
Retained Earnings -$259.3M
YoY Change
Common Stock $565.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $608.1M $519.2M
YoY Change
Total Liabilities & Shareholders Equity $684.8M $591.5M
YoY Change 15.77% 42.12%

Cashflow Statement

Concept 2019 Q2 2018 Q2
OPERATING ACTIVITIES
Net Income -$16.03M -$25.87M
YoY Change -38.02% 235.96%
Depreciation, Depletion And Amortization $1.000M $900.0K
YoY Change 11.11% 80.0%
Cash From Operating Activities $109.1M -$28.50M
YoY Change -482.81% 120.93%
INVESTING ACTIVITIES
Capital Expenditures -$2.500M -$1.600M
YoY Change 56.25% 45.45%
Acquisitions
YoY Change
Other Investing Activities -$99.80M -$188.6M
YoY Change -47.08% -1879.25%
Cash From Investing Activities -$102.5M -$190.2M
YoY Change -46.11% -2123.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.900M 2.300M
YoY Change 69.57% 109.09%
NET CHANGE
Cash From Operating Activities 109.1M -28.50M
Cash From Investing Activities -102.5M -190.2M
Cash From Financing Activities 3.900M 2.300M
Net Change In Cash 10.50M -216.4M
YoY Change -104.85% 8916.67%
FREE CASH FLOW
Cash From Operating Activities $109.1M -$28.50M
Capital Expenditures -$2.500M -$1.600M
Free Cash Flow $111.6M -$26.90M
YoY Change -514.87% 127.97%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Trading Symbol
TradingSymbol
XNCR
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Central Index Key
EntityCentralIndexKey
0001326732
dei Entity Registrant Name
EntityRegistrantName
Xencor Inc
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
56529398
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
56279542
CY2018Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2018Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2019Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2019Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
950000
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
50000
CY2019Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2019-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36182
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-1622502
dei Entity Address Address Line1
EntityAddressAddressLine1
111 West Lemon Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
Monrovia
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
91016
dei City Area Code
CityAreaCode
626
dei Local Phone Number
LocalPhoneNumber
305-5900
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
50000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
950000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
311000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
315727000
CY2019Q2 us-gaap Assets
Assets
684753000
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12128000
dei Entity Shell Company
EntityShellCompany
false
CY2019Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
56620260
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32557000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26246000
CY2019Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
472613000
CY2018Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
268115000
CY2019Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10130000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10187000
CY2019Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
402000
CY2018Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
804000
CY2019Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11307000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10375000
CY2019Q2 us-gaap Assets Current
AssetsCurrent
527009000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11813000
CY2019Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
13522000
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
11969000
CY2019Q2 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
120966000
CY2018Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
236108000
CY2019Q2 us-gaap Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
402000
CY2018Q4 us-gaap Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
804000
CY2019Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10726000
CY2018Q4 us-gaap Assets
Assets
576732000
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
8994000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3797000
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6226000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9662000
CY2018Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
315000
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2214000
CY2019Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
45478000
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
40079000
CY2019Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
800000
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
63712000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
53853000
CY2018Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1198000
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9650000
CY2019Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
3300000
CY2019Q2 us-gaap Liabilities
Liabilities
76662000
CY2018Q4 us-gaap Liabilities
Liabilities
55051000
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2019Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9520000
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
39057000
CY2019Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
3615000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
64962000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-55361000
CY2018Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
2483000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11270000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
6501000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
3637000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
18764000
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56529398
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56279542
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
565000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
563000
CY2019Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
865163000
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
845366000
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1629000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-971000
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-259266000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-323277000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
608091000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
521681000
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
684753000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
576732000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19485000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
131424000
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
33299000
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23332000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
61481000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
49418000
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5758000
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4958000
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
28290000
us-gaap Operating Expenses
OperatingExpenses
72751000
us-gaap Operating Expenses
OperatingExpenses
58938000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-19572000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-28290000
us-gaap Operating Income Loss
OperatingIncomeLoss
58673000
us-gaap Operating Income Loss
OperatingIncomeLoss
-58938000
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-27000
CY2018Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-62000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-212000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-60000
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3588000
CY2018Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2421000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6289000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3577000
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15984000
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25869000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-16034000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26246000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-25869000
us-gaap Net Income Loss
NetIncomeLoss
64012000
us-gaap Net Income Loss
NetIncomeLoss
-55361000
CY2019Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
1284000
CY2018Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
193000
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
2600000
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-200000
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14750000
CY2018Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-25676000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
66612000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-55561000
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.14
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.07
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.07
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56399255
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55678990
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56351377
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51738348
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56399255
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55678990
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58042819
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51738348
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
521681000
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
667000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
81361000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5856000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
609565000
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3239000
CY2019Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
734000
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14750000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9303000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
608091000
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest Adjusted Balance1
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1
316464000
CY2018Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
245505000
CY2018Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1110000
CY2018Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-29886000
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4471000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
537664000
CY2018Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-1000
CY2018Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1805000
CY2018Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
504000
CY2018Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-25676000
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4882000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
519178000
us-gaap Profit Loss
ProfitLoss
64012000
us-gaap Profit Loss
ProfitLoss
-55361000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2003000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1552000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1876000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-406000
us-gaap Share Based Compensation
ShareBasedCompensation
15159000
us-gaap Share Based Compensation
ShareBasedCompensation
9353000
us-gaap Noncash Project Abandonment Costs
NoncashProjectAbandonmentCosts
90000
us-gaap Noncash Project Abandonment Costs
NoncashProjectAbandonmentCosts
50000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-5000
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-122000
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
140000
us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
154000
us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
595000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
932000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6468000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5197000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1953000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3436000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
443000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1604000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-157000
xncr Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-1513000
xncr Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
206000
xncr Increase Decrease In Lease Liabilities And Right Of Use Assets
IncreaseDecreaseInLeaseLiabilitiesAndRightOfUseAssets
1448000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
8699000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
90428000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-52664000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
244499000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
285809000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
2164000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
882000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1867000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3416000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
159773000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
112526000
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
-86000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-88757000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-177495000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
3906000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
2915000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
734000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
504000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
260245000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
14741000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4640000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
248923000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6311000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9353000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16528000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32557000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35292000
us-gaap Interest Paid Net
InterestPaidNet
7000
us-gaap Interest Paid Net
InterestPaidNet
6000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
150000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
170000
us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
2600000
us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
-200000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Times New Roman';font-size:12pt;text-indent:36pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt;">The preparation of interim financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, other comprehensive gain (loss) and the related disclosures. On an ongoing basis, management evaluates its estimates, including estimates related to its accrued clinical trial and manufacturing development expenses, stock-based compensation expense, intangible assets and related amortization. Significant estimates in these interim financial statements include estimates made for accrued research and development expenses, stock-based compensation expenses, intangible assets and related amortization, estimated standalone selling price of performance obligations, and recoverability of deferred tax assets.</p>
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56351377
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
134635000
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
167000
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9303000
CY2018Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4882000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15159000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9353000
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9303000
CY2018Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4882000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15159000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51738348
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56399255
us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2019Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
616460000
CY2018Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
522493000
CY2018Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2018Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2019Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2019Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-16034000
CY2018Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-25869000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
64012000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-55361000
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56399255
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55678990
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55678990
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58042819
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51738348
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.14
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.07
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.07
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1396000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2723000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2608000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2220000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1351000
CY2019Q2 xncr Lessee Operating Lease Liability Payments Due Year Six
LesseeOperatingLeaseLiabilityPaymentsDueYearSix
1371000
CY2019Q2 xncr Lessee Operating Lease Liability Payments Due After Year Six
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix
2282000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
13951000
CY2019Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2087000
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
11864000
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2214000
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9650000
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
11864000
us-gaap Operating Lease Cost
OperatingLeaseCost
1400000
us-gaap Operating Lease Payments
OperatingLeasePayments
1200000
us-gaap Operating Lease Expense
OperatingLeaseExpense
1200000
CY2019Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y9M18D
CY2019Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.055
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19500000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
131400000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19500000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
131400000
CY2019Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
48800000
CY2018Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
60100000
CY2019Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
45500000
CY2019Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
3300000
CY2019Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1689000
CY2018Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1933000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1774000
xncr Cash And Cash Equivalents And Marketable Securities Amortized Cost
CashAndCashEquivalentsAndMarketableSecuritiesAmortizedCost
614821000
CY2019Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1686000
CY2019Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
47000
CY2019Q2 us-gaap Investments
Investments
616460000
CY2019Q2 us-gaap Investments
Investments
616460000
CY2018 xncr Cash And Cash Equivalents And Marketable Securities Amortized Cost
CashAndCashEquivalentsAndMarketableSecuritiesAmortizedCost
523454000
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
188000
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1149000
CY2018Q4 us-gaap Investments
Investments
522493000
CY2018Q4 us-gaap Investments
Investments
522493000
CY2019Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
471958000
CY2019Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
472613000
CY2019Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
119982000
CY2019Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
120966000
CY2019Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
591940000
CY2019Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
593579000
CY2019Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
52226000
CY2019Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
47000
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
260891000
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
982000

Files In Submission

Name View Source Status
0001558370-19-007346-index-headers.html Edgar Link pending
0001558370-19-007346-index.html Edgar Link pending
0001558370-19-007346.txt Edgar Link pending
0001558370-19-007346-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xncr-20190630.xsd Edgar Link pending
xncr-20190630ex101f233ac.htm Edgar Link pending
xncr-20190630ex3110aa7a5.htm Edgar Link pending
xncr-20190630ex3120d7112.htm Edgar Link pending
xncr-20190630ex3211e7c7c.htm Edgar Link pending
xncr-20190630x10q.htm Edgar Link pending
xncr-20190630x10q_htm.xml Edgar Link completed
xncr-20190630_cal.xml Edgar Link unprocessable
xncr-20190630_def.xml Edgar Link unprocessable
xncr-20190630_lab.xml Edgar Link unprocessable
xncr-20190630_pre.xml Edgar Link unprocessable